Pre-Open 11/20: (ARAV) (I) (TGT) Higher (PDD) (URBN) (MUX) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Organogenesis Holding (ORGO) Prices 9M Share Common Offering at $5/Sh
November 22, 2019 5:36 AM ESTOrganogenesis Holdings Inc. (NASDAQ: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced the pricing of an underwritten public offering of 9,000,000 shares of its Class A common stock,... More
CRISPR Therapeutics (CRSP) Prices 4.25M Share Common Offering at $64.50/Sh
November 21, 2019 5:52 AM ESTCRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, today announced the pricing of an underwritten public offering of 4,250,000 common shares at a public offering price of $64.50 per share. In addition, the underwriters have a 30-day... More
Lowe's (LOW) PT Raised to $134 at RBC Capital; Remain 'Aggressive Buyers'
November 20, 2019 1:22 PM ESTRBC Capital analyst Scot Ciccarelli raised the price target on Lowe's (NYSE: LOW) to $134.00 (from $129.00) while maintaining a Outperform rating following results.
The analyst commented, "Lowes US comp results of +3% were a bit better than investor expectations following Home Depots report... More
Aravive Inc. (ARAV) PT Raised to $31 at H.C. Wainwright
November 20, 2019 12:14 PM ESTH.C. Wainwright analyst Joseph Pantginis raised the price target on Aravive Inc. (NASDAQ: ARAV) to $31.00 (from $18.00) while maintaining a Buy rating.
The analyst commented, "This morning, Aravive announced new positive data from the ongoing Phase 1b portion of the Phase 1b/2 clinical trial of... More
